Assessment of Quality of Life in Irritable Bowel Syndrome Patients

KAYA GÜVEN, GÜLŞEN; Kiyak, Emine

doi:10.5152/ArcHealthSciRes.2020.582169

Assessment of Quality of Life in Irritable Bowel Syndrome Patients

Gülşen KAYA GÜVEN, (Ağrı İl Sağlık Müdürlüğü, Merkez Toplum Sağlığı Merkezi, Ağrı, Türkiye)

Emine KIYAK (Atatürk Üniversitesi, Hemşirelik Fakültesi, Erzurum, Türkiye)

Archives of health science and research (Online)

21 1

Yıl: 2020 Cilt: 7 Sayı: 2 Sayfa Aralığı: 146 - 154 Metin Dili: İngilizce DOI: 10.5152/ArcHealthSciRes.2020.582169 İndeks Tarihi: 30-10-2020

Assessment of Quality of Life in Irritable Bowel Syndrome Patients

Öz:

Objective: This study was conducted to assess the quality of life of patients with irritable bowel syndrome.Material and Methods: The data for the study were collected from 201 patients who were referred to Agrı Hospital, Internal Diseases and Gastroenterology Polyclinic and who were diagnosed with irritable bowel syndrome between February and September 2015. A questionnaire form and the irritable bowel syndrome quality of life questionnaire (IBS-QOL) were used for data collection. Percentage, average, Mann–Whitney U test, and Kruskal–Wallis test were used in the assessment of the data.Results: The average of the patients’ quality of life total scores was found to be 61.4±18.41. Looking at the sub-dimension score averages in IBS-QOL, dysphoria was found to be 60.29±22.62; activity, 56.36±21.18; body image, 63.71±23.90; health worry, 53.11±26.89; food avoidance, 43.91±24.13; social reaction, 69.68±22.83; activity, 87.94±25.11; and social relation 69.40±26.00. A significant difference was found between quality of life and patients’ marital status (p=0.049), level of income (p=0.000), type of treatment (p=0.026), frequency of complaints (p=0.008), and general health perception (p=0.000).Conclusion: The quality of life of the patients in the sample was found to be mildly above the average. Whereas the most affected sub-dimension was food avoidance, the least affected sub-dimension was activity. It was found that married patients, those with a low income, those using alternative methods along with drugs in treatment, those whose complaints varied depending on the diet and the medication and lasted every day, and those who had a very poor perception of their general health were found to have a significantly low quality of life.

Anahtar Kelime:

İrritabl Bağırsak Sendromlu Hastalarda Yaşam Kalitesinin Değerlendirilmesi

Öz:

Amaç: Araştırma irritabl bağırsak sendromlu hastalarda yaşam kalitesinin değerlendirilmesi amacıyla yapıldı. Gereç ve Yöntem: Araştırmanın verileri, Ağrı’daki bir hastanenin Dâhiliye ve Gastroenteroloji Polikliniğine Şubat-Eylül 2015 tarihleri arasında gelen ve irritabl bağırsak sendromu tanısı olan 201 hasta ile yapıldı. Verilerin toplanmasında; anket formu ve İrritabl Bağırsak Sendromu Yaşam Kalitesi Ölçeği (IBS-QOL) kullanıldı. Verilerin değerlendirilmesinde yüzdelik ortalama, Mann Whitney U testi ve Kruskall Wallis testi kullanıldı. Bulgular: Hastaların yaşam kalitesi toplam puan ortalaması 61,34±18,41 bulundu, Yaşam kalitesi alt boyut puan ortalamalarından disfori 60,29±22,62, aktivite 56,36±21,18, beden imgesi 63,71±23,90, sağlık endişesi 53,11±26,89, yiyeceklerden kaçınma 43,91±24,13, sosyal tepki 69,68±22,83, seksüalite 87,94±25,11 ve sosyal ilişki 69,40±26,00 olarak bulundu. Hastaların medeni durumu (p=0.049), gelir durumu (p=0.000), tedavi türü (p=0.026), yakınma sıklığı (p=0.008) ve genel sağlık algısı (p=0.000) ile yaşam kalitesi arasında önemli bir fark olduğu bulundu. Sonuç: Hastaların yaşam kalitesinin ortalamanın biraz üstünde olduğu bulundu. Alt boyutlardan en çok etkilenen yiyeceklerden kaçınma iken en az etkilenenin cinsel yaşantı olduğu tespit edildi. Evli hastaların, geliri az olanların, tedavide ilaçla birlikte alternatif yöntem kullananların, şikâyetleri diyete ve ilaca bağlı olarak değişen, her gün şikayeti olan ve genel sağlık algısı kötü olanların yaşam kalitesinin önemli bir şekilde düşük olduğu tespit edildi.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther 2018; 35: 289-310.
2. Henström M, D'Amato M. Genetics of İrritable Bowel Syndrome. Mol Cell Pediatr 2016; 3: 7.
3. Adeniyi OF, Lesi OA, Olatona FA, Esezobor CI, Ikobah JM. Irritable Bowel Syndrome in Adolescents in Lagos. Pan Afr Med J 2017; 28: 93.
4. Håkanson C. Everyday life, healthcare, and Self-Care Management among People with Irritable Bowel Syndrome: An integrative Review of Qualitative Research. Gastroenterol Nurs 2014; 37: 217-25.
5. Özden A, Köksal A, Oğuz D, Çiçek B, Yılmaz U, Dağlı Ü, et al. Türkiye'de Birinci Basamak Sağlık Kurumlarında İrritabl Barsak Sendromu Görülme Sıklığı. Akademik Gastroenteroloji Dergisi 2006; 5: 4-15.
6. Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, et al. The global Prevalence of IBS in Adults Remains Elusive due to the Heterogeneity of Studies: A Rome Foundation Working Team Literature Review. Gut 2017; 66: 1075-82.
7. Kılıç SP, Ovayolu N, Koruk M. İrritabl Barsak Sendromlu Hastalarda Yaşam Kalitesi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2017; 2: 27-32.
8. Heavey E, Daniel E. Limiting FODMAP Consumption for Patients with IBS. Nursing 2018; 48: 54-7.
9. Weaver KR, Melkus GDE, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017; 117: 48-55.
10. Chang F-Y. Irritable Bowel Syndrome: The Evolution of Multi-Dimensional Looking and Multidisciplinary Treatments. World J Gastroenterol 2014; 20: 2499-514.
11. Chira A, Filip M, Dumitrascu DL. Patterns of Alternation in Irritable Bowel Syndrome. Clujul Med 2016; 89: 220-3.
12. Quigley EM. The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS). J Clin Med 2018; 7: 6.
13. Mazzawi T, El-Salhy M. Effect of Diet and Individual Dietary Guidance on Gastrointestinal Endocrine Cells in Patients with Irritable Bowel Syndrome. Int J Mol Med 2017; 40: 943-952.
14. Eriksson EM, Andrén KI, Kurlberg GK, Eriksson HT. Aspects of the Non-Pharmacological Treatment of Irritable Bowel Syndrome. World J Gastroenterol 2015; 21: 11439-49.
15. Gwee KA, Ghoshal UC, Chen M. Irritable Bowel Syndrome İn Asia: Pathogenesis, Natural History, Epidemiology, And Management. J Gastroenterol Hepatol 2018; 33: 99-110.
16. Qureshi SR, Abdelaal AM, Janjua ZA, Alasmari HA, Obad AS, Alamodi A, et al. Irritable Bowel Syndrome: A Global Challenge Among Medical Students. Cureus 2016; 8: e721.
17. Kalkan S. Diyabetes Mellitus ve Oral Glukoz tolerans Testi Bozuk Olan Hastalarda Dispeptik Yakınmaların ve İrritabl Barsak Sendromunun Sıklığı ve Yaşam Kalitesi Üzerine Olan Etkilerinin Değerlendirilmesi (Uzmanlık Tezi). Çanakkale Onsekiz Mart Üniversitesi, Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Çanakkale; 2013.
18. Yastıbaş C. Leventhal'in Hastalık Davranışlarının Kendini Düzenleyici Modeli Kapsamında İrritabl Barsak Sendromu (İBS) Hastalarının Psikolojk Sıkıntı ve Yaşam Kalitesi Düzeylerinin İncelenmesi (Yüksek Lisans Tezi). Dokuz Eylül Üniversitesi, Psikoloji Anabilim Dalı, İzmir; 2016.
19. Kopczyńska M, Mokros Ł, Pietras T, Małecka-Panas E. Quality of life and depression in patients with irritable bowel syndrome. Prz Gastroenterol 2018; 13: 102-108.
20. Alhan C. İrritabl Barsak Sendromu Haastalarında Yaşam Kalitesi, Hastalığın Ruhsal Durum ile Etkileşimi ve Psikiyatrik Eş Tanılar (Uzmanlık Tezi). Abant İzzet Baysal Üniversitesi, Ruh Sağlığı ve Hastalıkları Anabilim Dalı, Bolu; 2012.
21. Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, et al. Irritable bowel syndrome and quality of life in a community-dwelling population in Japan. Int J Psychiatry Med 2018; 53: 159-170.
22. Ghiyasvandian S, Ghorbani M, Zakerimoghadam M, Purfarzad Z, Kazemnejad A. The Effects of a Self-Care Program on the Severity of Symptoms and Quality of Life of Patients With Irritable Bowel Syndrome. Gastroenterol Nurs 2016; 39: 359-65.
23. Heitkemper M, Jarrett M, Jun S-E. Update on Irritable Bowel Syndrome Program of Research. J Korean Acad Nurs 2013; 43: 579-86.
24. Anastasi JK, Capili B. Managing Irritable Bowel Syndrome: How to Help Patients Control This Life-Altering Condition. Am J Nurs 2013; 113: 42-53.
25. Doğan BÇ, Karabayraktar T, Dabak MR. İrritabl Barsak Sendromu ve Yaşam Kalitesi. J Fam Med-Special Topics 2014; 5: 80-82.
26. Çapık C. Statistical Power Analysis and It's Use in Nursing Studies: Basic Information. J Anatolian Nurs Health 2014; 17: 268-74.
27. Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, et al. Health-Related Quality of Life, Work Productivity, and Health Care Resource Utilization of Subjects with Irritable Bowel Syndrome: Baseline Results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a Naturalistic Study. Clin Ther 2006; 28: 1726-35.
28. Uran BNO, Karadakovan A, Vardar R, Bor S. Psychometric Properties of the Irritable Bowel Syndrome Quality of Life Scale in Turkey. J Hepatol Gastroint Dis 2016; 2: 137.
29. Hou X, Chen S, Zhang Y, Sha W, Yu X, Elsawah H, et al. Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS-Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China. Clin Drug Investig 2014; 34: 783-93.
30. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al. Health-Related Quality of Life and Cost Impact of Orritable Bowel Syndrome in a UK Primary Care Setting. Pharmacoeconomics 2002; 20: 455-62.
31. Sherwin LB, Leary E, Henderson WA. The Association of Catastrophizing with Quality-of-Life Outcomes in Patients with Irritable Bowel Syndrome. Qual Life Res 2017; 26: 2161-70.
32. Ahmed A, Mohamed RA, Sliem HA, Eldein HN. Pattern of Irritable Bowel Syndrome and Its Impact on Quality of Life in Primary Health Care Center Attendees, Suez Governorate, Egypt. Pan Afr Med J 2011; 9: 5.
33. Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, et al. Intestinal Symptoms and Psychological Factors Jointly Affect Quality of Life of Patients with Irritable Bowel Syndrome with Diarrhea. Health Qual Life Outcomes 2015; 13: 49.
34. Lacy BE. The Science, Evidence, and Practice of Dietary İnterventions in İrritable Bowel Syndrome. Clin Gastroenterol Hepatol 2015; 13: 1899-906.
35. Park JM, Choi MG, Kim YS, Choi CH, Choi SC, Hong SJ, et al. Quality of life of Patients with Irritable Bowel Syndrome in Korea. Qual Life Res 2009; 18: 435-46.
36. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of Irritable Bowel Syndrome on Health-Related Quality of Life. Gastroenterology 2000; 119: 654-60.
37. Si JM, Wang L-J, Chen SJ, Sun LM, Dai N. Irritable Bowel Syndrome Consulters in Zhejiang Province: The Symptoms Pattern, Predominant Bowel Habit Subgroups and Quality of Life. World J Gastroenterol 2004; 10: 1059-64.
38. Özgen K. Çanakkale Bölgesi Aile Sağlığı Merkezine Başvuranlarda İrritabl Barsak Sendromu Yaygınlığı ve Hastaların Özellikleri (Uzmanlık Tezi). Çanakkale Onsekiz Mart Üniversitesi, Tıp Fakültesi Aile Hekimliği Anabilim Dalı, Çanakkale; tez2013.
39. Dökmen ZY. Menopoz, Beden İmgesi Ve Ruh Sağlığı. Türk Psikoloji Yazıları 2009. Available from: https://www.psikolog.org.tr/tr/yayinlar/dergiler/1031828/tpy1301996120090000m000137.pdf.
40. Parlar S. Hassas Barsak Sendromu Olan Hastalarda Yaşam Kalitesinin Değerlendirilmesi (Yüksek Lisans Tezi). Gaziantep Üniversitesi, İç Hastalıklar Hemşireliği Anabilim Dalı, Gaziantep; 2004.
41. Lovell RM, Ford AC. Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-Analysis. Clin Gastroenterol Hepatol 2012; 10: 712-21.
42. Dehkordi AH, Solati K. The Effects of Cognitive Behavioral Therapy and Drug Therapy on Quality of Life and Symptoms of Patients With Irritable Bowel Syndrome. J Adv Pharm Technol Res 2017; 8: 67-72.
43. Başaran H. İrritabl Barsak Sendromlu Hastaların Beslenme Düzeylerinin Değerlendirilmesi (Yüksek Lisans Tezi). Haliç Üniversitesi, Beslenme ve Diyetetik, İstanbul; 2015.
44. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-Reported Food-Related Gastrointestinal Symptoms İn IBS Are Common And Associated With More Severe symptoms and reduced quality of life. Am J Gastroenterol 2013; 108: 634-41.
45. Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, et al. Irritable Bowel Syndrome and Quality of Life in a Community-Dwelling Population in Japan. Int J Psychiatry Med 2018; 53: 159-70.
46. Simrén M, Svedlund J, Posserud I, Björnsson ES, Abrahamsson H. Health-related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases. Clin Gastroenterol Hepatol 2006; 4: 187-95.

APA	KAYA GÜVEN G, Kiyak E (2020). Assessment of Quality of Life in Irritable Bowel Syndrome Patients. , 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
Chicago	KAYA GÜVEN GÜLŞEN,Kiyak Emine Assessment of Quality of Life in Irritable Bowel Syndrome Patients. (2020): 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
MLA	KAYA GÜVEN GÜLŞEN,Kiyak Emine Assessment of Quality of Life in Irritable Bowel Syndrome Patients. , 2020, ss.146 - 154. 10.5152/ArcHealthSciRes.2020.582169
AMA	KAYA GÜVEN G,Kiyak E Assessment of Quality of Life in Irritable Bowel Syndrome Patients. . 2020; 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
Vancouver	KAYA GÜVEN G,Kiyak E Assessment of Quality of Life in Irritable Bowel Syndrome Patients. . 2020; 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
IEEE	KAYA GÜVEN G,Kiyak E "Assessment of Quality of Life in Irritable Bowel Syndrome Patients." , ss.146 - 154, 2020. 10.5152/ArcHealthSciRes.2020.582169
ISNAD	KAYA GÜVEN, GÜLŞEN - Kiyak, Emine. "Assessment of Quality of Life in Irritable Bowel Syndrome Patients". (2020), 146-154. https://doi.org/10.5152/ArcHealthSciRes.2020.582169

APA	KAYA GÜVEN G, Kiyak E (2020). Assessment of Quality of Life in Irritable Bowel Syndrome Patients. Archives of health science and research (Online), 7(2), 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
Chicago	KAYA GÜVEN GÜLŞEN,Kiyak Emine Assessment of Quality of Life in Irritable Bowel Syndrome Patients. Archives of health science and research (Online) 7, no.2 (2020): 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
MLA	KAYA GÜVEN GÜLŞEN,Kiyak Emine Assessment of Quality of Life in Irritable Bowel Syndrome Patients. Archives of health science and research (Online), vol.7, no.2, 2020, ss.146 - 154. 10.5152/ArcHealthSciRes.2020.582169
AMA	KAYA GÜVEN G,Kiyak E Assessment of Quality of Life in Irritable Bowel Syndrome Patients. Archives of health science and research (Online). 2020; 7(2): 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
Vancouver	KAYA GÜVEN G,Kiyak E Assessment of Quality of Life in Irritable Bowel Syndrome Patients. Archives of health science and research (Online). 2020; 7(2): 146 - 154. 10.5152/ArcHealthSciRes.2020.582169
IEEE	KAYA GÜVEN G,Kiyak E "Assessment of Quality of Life in Irritable Bowel Syndrome Patients." Archives of health science and research (Online), 7, ss.146 - 154, 2020. 10.5152/ArcHealthSciRes.2020.582169
ISNAD	KAYA GÜVEN, GÜLŞEN - Kiyak, Emine. "Assessment of Quality of Life in Irritable Bowel Syndrome Patients". Archives of health science and research (Online) 7/2 (2020), 146-154. https://doi.org/10.5152/ArcHealthSciRes.2020.582169